NCT04924231

Brief Summary

we aimed to analyze the effects of cataract surgery using a 1.8-mm steep-axis clear corneal incision (CCI) on the posterior corneal surfaces based on the keratometry from the rotating Scheimpflug imaging device (Pentacam HR) in candidates for toric intraocular lens (IOL) implantation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

June 8, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2021

Completed
Last Updated

June 11, 2021

Status Verified

June 1, 2021

Enrollment Period

1.2 years

First QC Date

June 8, 2021

Last Update Submit

June 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • corneal astigmatism

    postoperative anterior, posterior and total corneal astigmatism

    post 1 month

Interventions

astigmatismBEHAVIORAL

astigamatism at least 1 month after the cataract surgery

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients, who underwent cataract surgery with a 1.8-mm steep-axis CCI at the Eye Center, the Second Affiliated Hospital of Zhejiang University

You may qualify if:

  • patients aged at least 45 years old who were scheduled for cataract surgery; (2) regular corneal astigmatism ≥ 1.0 D; (3) the imaging quality parameter (QS) of Pentacam HR was "OK"; and (4) follow-up time ≥1.0 month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, China

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2021

First Posted

June 11, 2021

Study Start

February 1, 2017

Primary Completion

March 30, 2018

Study Completion

May 1, 2018

Last Updated

June 11, 2021

Record last verified: 2021-06

Locations